Centene (CNC) to Release Earnings on Friday

Centene (NYSE:CNC - Get Free Report) is expected to be issuing its Q1 2025 quarterly earnings data before the market opens on Friday, April 25th. Analysts expect Centene to post earnings of $2.20 per share and revenue of $43.16 billion for the quarter. Centene has set its FY 2025 guidance at 7.250- EPS.

Centene (NYSE:CNC - Get Free Report) last issued its quarterly earnings data on Tuesday, February 4th. The company reported $0.80 EPS for the quarter, topping analysts' consensus estimates of $0.49 by $0.31. Centene had a return on equity of 13.85% and a net margin of 2.03%. The company had revenue of $40.81 billion for the quarter, compared to analysts' expectations of $38.78 billion. During the same quarter in the previous year, the firm posted $0.45 earnings per share. The firm's quarterly revenue was up 3.4% on a year-over-year basis. On average, analysts expect Centene to post $7 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Centene Stock Up 3.1 %

Shares of CNC stock traded up $1.88 during trading hours on Wednesday, reaching $62.11. The company had a trading volume of 4,219,916 shares, compared to its average volume of 4,716,547. The stock's fifty day simple moving average is $59.97 and its 200 day simple moving average is $61.13. The company has a market capitalization of $30.81 billion, a P/E ratio of 9.95, a price-to-earnings-growth ratio of 0.80 and a beta of 0.53. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.10 and a current ratio of 1.11. Centene has a twelve month low of $55.03 and a twelve month high of $80.59.

Wall Street Analysts Forecast Growth

CNC has been the topic of a number of analyst reports. Wells Fargo & Company dropped their price objective on shares of Centene from $76.00 to $72.00 and set an "overweight" rating on the stock in a research note on Friday, February 14th. Jefferies Financial Group upgraded shares of Centene from an "underperform" rating to a "hold" rating and boosted their price objective for the stock from $53.00 to $64.00 in a report on Tuesday, April 8th. Guggenheim assumed coverage on Centene in a research note on Wednesday, April 9th. They set a "neutral" rating for the company. Argus cut Centene from a "buy" rating to a "hold" rating in a research note on Thursday, February 6th. Finally, Robert W. Baird cut their price target on shares of Centene from $71.00 to $69.00 and set a "neutral" rating on the stock in a report on Tuesday, April 15th. Seven analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $80.69.

About Centene

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.